Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed. For years, mitochondrial ...

Today on Louisiana Considered, we learn why the state’s reserve funds are currently flush with cash — but may not stay that ...

Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...

Pfizer's phase II study evaluating CDK4 inhibitor, atirmociclib, in 2L metastatic breast cancer meets primary endpoint. Supports oncology pipeline progress.

Croissants for a Cure takes place at Renaud's on Coast Village Road to raise money for those fighting blood cancer. It is a ...

After repeated unsuccessful cancer treatments, even the strongest patients can lose hope. But former University of Virginia ...

Universal month-3 NGF MRD negativity (10⁻⁵) followed short-course VRd or daratumumab-based induction and single-infusion ...

Multinational real-world use across 23 centers yielded efficacy broadly aligned with MajesTEC-1, supporting external validity for teclistamab in late-line RRMM. Response depth tracked with durability, ...

UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T ...

For years, one of the most powerful weapons against certain blood cancers, called CAR-T cell therapy, has required an elaborate process: Doctors ...

A man who was told his shoulder pain was due to acid reflux discovered he had incurable blood cancer - after pushing for a ...